Elías Cuesta‐Llavona

Author

Hospital Universitario Central de Asturias ORCID

Also Known As

E Cuesta-Llavona, Elias Cuesta-LLavona, Elias Cuesta-Llavona, Elías Cuesta-LLavona, Elías Cuesta-Lavona, Elías Cuesta-Llavona, Elías Cuesta‐Llavona

Publications

702

Citations

H-Index

Concepts

All Affiliations

Hospital Universitario Central de Asturias Instituto de Investigación Sanitaria del Principado de Asturias Universidad de Oviedo Centro de Investigación Biomédica en Red de Enfermedades Respiratorias Instituto de Salud Carlos III

About

Elías Cuesta‐Llavona is an author at Hospital Universitario Central de Asturias specializing in medicine, covid-19, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	499
2	Immunology	6	6	412
3	Public Health	5	5	120
4	Epidemiology	4	4	80
5	Health Sciences	1	1	23

Elías Cuesta‐Llavona

Publications

604

Citations

H-Index

Page 1

	Year	Citations
Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome Juan Gómez, Guillermo M. Albaiceta, Marta García‐Clemente, Gene Cardiovascular DiseaseVascular PharmacologyImmunologyVascular BiologyMedicine	2020	242
The Interferon-induced transmembrane protein 3 gene (IFITM3) rs12252 C variant is associated with COVID-19 Juan Gómez, Guillermo M. Albaiceta, Elías Cuesta‐Llavona, Cytokine Molecular VirologyPathogenesisImmunologyViral PathogenesisPathology	2020	86
Gene variants in the NF-KB pathway (NFKB1, NFKBIA, NFKBIZ) and risk for early-onset coronary artery disease Eliécer Coto, Julián R. Reguero, Pablo Avanzas, Immunology Letters Nf-kb PathwayCardiovascular DiseaseGeneticsGenetic EpidemiologyHuman Polymorphism	2019	40
Association between the interferon-induced transmembrane protein 3 gene (IFITM3) rs34481144 / rs12252 haplotypes and COVID-19 Elías Cuesta‐Llavona, Guillermo M. Albaiceta, Marta García‐Clemente, Current Research in Virological Science	2021	31
Transcriptomic clustering of critically ill COVID-19 patients Cecilia López‐Martínez, Paula Martín-Vicente, Juan Gómez de Oña, European Respiratory Journal	2022	30
Variant-genetic and transcript-expression analysis showed a role for the chemokine-receptor CCR5 in COVID-19 severity Elías Cuesta‐Llavona, Juan Gómez, Guillermo M. Albaiceta, International Immunopharmacology Chemokine-receptor Ccr5MedicineCovid-19 PandemicImmunologyTranscript-expression Analysis	2021	28
The FCGR2A rs1801274 polymorphism was associated with the risk of death among COVID-19 patients Rocío López‐Martínez, Guillermo M. Albaiceta, Laura Amado‐Rodríguez, Clinical Immunology Fcgr2a Rs1801274 PolymorphismDisease SusceptibilityPathogenesisGenetic EpidemiologyHuman Polymorphism	2022	24
Genetic variants in the NF-κB signaling pathway (NFKB1, NFKBIA, NFKBIZ) and risk of critical outcome among COVID-19 patients Daniel G. Camblor, Daniel Miranda, Guillermo M. Albaiceta, Human Immunology Disease SusceptibilityGenetic VariantsMedicineGenetic EpidemiologyImmunology	2022	24
Characterization of Left Ventricular Non-Compaction Cardiomyopathy Rebeca Lorca, Isaac Pascual, Aurora Astudillo, Journal of Clinical Medicine Heart FailureGenetic TestingPathologyCongenital Heart AnomalyStructural Heart Disease	2020	23
The CCR5-delta32 variant might explain part of the association between COVID-19 and the chemokine-receptor gene cluster Juan Gómez, Elías Cuesta‐Llavona, Guillermo M. Albaiceta, ImmunodeficienciesImmunologyGenetic EpidemiologyPathologyHuman Polymorphism	2020	18

Page 1